Essity acquires distribution rights to wound care technology Sorbact in Australia and New Zealand
STOCKHOLM, April 6, 2021-
The leading global hygiene and health company Essity is acquiring the distribution rights to the wound care technology Sorbact in Australia and New Zealand from the Australian company Bayport Brands. In 2020, sales of Sorbact in the region amounted to AUD 1.7m (approximately SEK 11m).
“This acquisition underlines our ambition to accelerate growth in advanced wound care, where we showed good organic sales growth during the second half of 2020. It is also a good fit for our strategy to establish a stronger presence in Australia and New Zealand, where we – in addition to our successful Medical Solutions operations – are also in the final phase of the acquisition of Asaleo Care,” says Magnus Groth, President and CEO of Essity.
Not a subscriber?